Efficacy of Paroxetine (7.5 mg) in the treatment of menopause-associated vasomotor symptoms

被引：0
|
作者：
Belardo, Maria A. [1 ]
机构：
[1] Italian Hosp, Climacter Sect, Buenos Aires, DF, Argentina
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2019年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-4
引用
收藏
页码：1459 / 1459
页数：1
相关论文
共 50 条
  • [41] A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms
    David, Paru S.
    Smith, Taryn L.
    Nordhues, Hannah C.
    Kling, Juliana M.
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2022, 14 : 353 - 361
  • [42] Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT
    Johnson, Kimball A.
    Martin, Nancy
    Nappi, Rossella E.
    Neal-Perry, Genevieve
    Shapiro, Marla
    Stute, Petra
    Thurston, Rebecca C.
    Wolfman, Wendy
    English, Marci
    Franklin, Catherine
    Lee, Misun
    Santoro, Nanette
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (08): : 1981 - 1997
  • [43] One-year Maintenance of Efficacy and Safety of Desvenlafaxine in Women With Vasomotor Symptoms Associated With Menopause
    Pinkerton, Joann V.
    Archer, David F.
    Guico-Pabia, Christine J.
    Hwang, Eunhee
    Cheng, Ru-fong J.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (12): : 1367 - 1367
  • [44] Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause
    Notelovitz, M
    Cassel, D
    Hille, D
    Furst, KW
    Dain, MP
    VandePol, C
    Skarinsky, D
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (01) : 7 - 12
  • [45] Estradiol topical emulsion for the treatment of moderate-to-severe vasomotor symptoms associated with menopause
    Simon, James A.
    [J]. WOMENS HEALTH, 2007, 3 (01) : 29 - 37
  • [46] Review of Pharmacokinetics and Efficacy of Transdermal Non-Patch Estradiol for Treatment of Vasomotor Symptoms in Menopause
    Carroll, Nina
    Mann, Mark
    [J]. JOURNAL OF WOMENS HEALTH, 2009, 18 (05) : 746 - 747
  • [47] Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety
    Archer, David F.
    Dupont, Caroline M.
    Constantine, Ginger D.
    Pickar, James H.
    Olivier, Sophie
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (03) : 238.e1 - 238.e10
  • [48] Bazedoxifene plus conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause
    Tella, Sri Harsha
    Gallagher, John Christopher
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (17) : 2407 - 2420
  • [49] Phase 3 Study of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause
    Lederman, Samuel
    Shapiro, Marla
    Stute, Petra
    Lee, Misun
    Wang, Xuegong
    Neal-Perry, Genevieve
    [J]. OBSTETRICS AND GYNECOLOGY, 2022, 139 : 39S - 39S
  • [50] Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause
    Mirkin, Sebastian
    Komm, Barry
    Pickar, James H.
    [J]. WOMENS HEALTH, 2014, 10 (02) : 135 - 146
12345